FIRST EXTENSION - GRANTED
granted
on 08 Oct 2024
Last Applicant/ Owned by
B712
BROOKLINE
MA
02446
Serial Number
97042705 filed on 23rd Sep 2021
Registration Number
N/A
Correspondent Address
Sara M. Bauer
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SURGE
Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy Hydroge Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the field of immunotherapy; research and development in the field of oncology; pharmaceutical research and development; providing medical research and scientific research information in the fields of oncology and immunotherapy via a website
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Artificial biomaterial for delivery of immunotherapy; Artificial intraoperative biomaterial for delivery of immunotherapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Hydrogel for medical purposes; Natural biomaterial for delivery of immunotherapy; pharmaceutical preparations used to modulate an immune response; pharmaceutical preparations for the treatment of cancer and for enhancing immune response to tumors; therapeutic agents for impacting immune-stimulating cells; therapeutic agents for impacting immune-suppressive cells; pharmaceutical preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; biological preparations for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents in the form of injections for medical purposes for the prevention and treatment of oncological, viral, musculoskeletal, immune, autoimmune, blood, respiratory, metabolic, neurological, urological, neoplastic, fibrotic diseases and disorders, and pain; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, biomaterials to extend the release of immunotherapy treatments at the site of tumor resection; Natural intraoperative biomaterial for delivery of immunotherapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97042705
Mark Type
No Service Mark
Attorney Docket Number
No 120292.00042
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Oct 2024 | SOU EXTENSION 1 GRANTED |
| 08th Oct 2024 | SOU EXTENSION 1 FILED |
| 08th Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Oct 2024 | SOU TEAS EXTENSION RECEIVED |
| 23rd Apr 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 04th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 07th Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Jan 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |